The University of Chicago Header Logo

Connection

Jeffrey Hubbell to Humans

This is a "connection" page, showing publications Jeffrey Hubbell has written about Humans.
Connection Strength

1.192
  1. Blocking antibodies against integrin-a3, -aM, and -aMß2 de-differentiate myofibroblasts, and improve lung fibrosis and kidney fibrosis. Sci Rep. 2024 09 16; 14(1):21623.
    View in: PubMed
    Score: 0.032
  2. Cysteine-binding adjuvant enhances survival and promotes immune function in a murine model of acute myeloid leukemia. Blood Adv. 2024 Apr 09; 8(7):1747-1759.
    View in: PubMed
    Score: 0.031
  3. Synthetically mannosylated antigens induce antigen-specific humoral tolerance and reduce anti-drug antibody responses to immunogenic biologics. Cell Rep Med. 2024 01 16; 5(1):101345.
    View in: PubMed
    Score: 0.030
  4. Engineered IL-7 synergizes with IL-12 immunotherapy to prevent T cell exhaustion and promote memory without exacerbating toxicity. Sci Adv. 2023 12; 9(48):eadh9879.
    View in: PubMed
    Score: 0.030
  5. Mannose-Decorated Co-Polymer Facilitates Controlled Release of Butyrate to Accelerate Chronic Wound Healing. Adv Healthc Mater. 2023 10; 12(26):e2300515.
    View in: PubMed
    Score: 0.030
  6. Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvant. Biomaterials. 2021 11; 278:121159.
    View in: PubMed
    Score: 0.026
  7. Persistent antigen exposure via the eryptotic pathway drives terminal T cell dysfunction. Sci Immunol. 2021 02 26; 6(56).
    View in: PubMed
    Score: 0.025
  8. Conferring extracellular matrix affinity enhances local therapeutic efficacy of anti-TNF-a antibody in a murine model of rheumatoid arthritis. Arthritis Res Ther. 2019 12 23; 21(1):298.
    View in: PubMed
    Score: 0.023
  9. Recruitment of CD103+ dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy. Sci Adv. 2019 12; 5(12):eaay1357.
    View in: PubMed
    Score: 0.023
  10. Targeting inflammatory sites through collagen affinity enhances the therapeutic efficacy of anti-inflammatory antibodies. Sci Adv. 2019 11; 5(11):eaay1971.
    View in: PubMed
    Score: 0.023
  11. Targeted antibody and cytokine cancer immunotherapies through collagen affinity. Sci Transl Med. 2019 04 10; 11(487).
    View in: PubMed
    Score: 0.022
  12. Trojan horses for immunotherapy. Nat Nanotechnol. 2019 03; 14(3):196-197.
    View in: PubMed
    Score: 0.022
  13. Improving Efficacy and Safety of Agonistic Anti-CD40 Antibody Through Extracellular Matrix Affinity. Mol Cancer Ther. 2018 11; 17(11):2399-2411.
    View in: PubMed
    Score: 0.021
  14. Laminin heparin-binding peptides bind to several growth factors and enhance diabetic wound healing. Nat Commun. 2018 06 04; 9(1):2163.
    View in: PubMed
    Score: 0.021
  15. Human Kunitz-type protease inhibitor engineered for enhanced matrix retention extends longevity of fibrin biomaterials. Biomaterials. 2017 Aug; 135:1-9.
    View in: PubMed
    Score: 0.019
  16. Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses. J Allergy Clin Immunol. 2017 Nov; 140(5):1339-1350.
    View in: PubMed
    Score: 0.019
  17. Engineering growth factors for regenerative medicine applications. Acta Biomater. 2016 Jan; 30:1-12.
    View in: PubMed
    Score: 0.017
  18. Engineering antigen-specific immunological tolerance. Curr Opin Immunol. 2015 Aug; 35:80-8.
    View in: PubMed
    Score: 0.017
  19. Prescription for a pharmacyte. Sci Transl Med. 2015 Jun 10; 7(291):291fs23.
    View in: PubMed
    Score: 0.017
  20. Extracellular matrix-inspired growth factor delivery systems for bone regeneration. Adv Drug Deliv Rev. 2015 Nov 01; 94:41-52.
    View in: PubMed
    Score: 0.017
  21. Overcoming immunological barriers in regenerative medicine. Nat Biotechnol. 2014 Aug; 32(8):786-94.
    View in: PubMed
    Score: 0.016
  22. Long-lasting fibrin matrices ensure stable and functional angiogenesis by highly tunable, sustained delivery of recombinant VEGF164. Proc Natl Acad Sci U S A. 2014 May 13; 111(19):6952-7.
    View in: PubMed
    Score: 0.016
  23. Translating materials design to the clinic. Nat Mater. 2013 Nov; 12(11):963-6.
    View in: PubMed
    Score: 0.015
  24. Tissue, cell and engineering. Curr Opin Biotechnol. 2013 Oct; 24(5):827-9.
    View in: PubMed
    Score: 0.015
  25. Chemistry. Nanomaterials for drug delivery. Science. 2012 Jul 20; 337(6092):303-5.
    View in: PubMed
    Score: 0.014
  26. Drug development: longer-lived proteins. Chem Soc Rev. 2012 Apr 07; 41(7):2686-95.
    View in: PubMed
    Score: 0.013
  27. Extracellular matrix in angiogenesis: dynamic structures with translational potential. Exp Dermatol. 2011 Jul; 20(7):605-13.
    View in: PubMed
    Score: 0.013
  28. Drug development: Longer-lived proteins. Nature. 2010 Oct 28; 467(7319):1051-2.
    View in: PubMed
    Score: 0.012
  29. Improving protein pharmacokinetics by engineering erythrocyte affinity. Mol Pharm. 2010 Dec 06; 7(6):2141-7.
    View in: PubMed
    Score: 0.012
  30. The 12th-14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain. FASEB J. 2010 Dec; 24(12):4711-21.
    View in: PubMed
    Score: 0.012
  31. In vitro uptake of amphiphilic, hydrogel nanoparticles by J774A.1 cells. J Biomed Mater Res A. 2010 Jun 15; 93(4):1557-65.
    View in: PubMed
    Score: 0.012
  32. Materials engineering for immunomodulation. Nature. 2009 Nov 26; 462(7272):449-60.
    View in: PubMed
    Score: 0.011
  33. Lymphatic drainage function and its immunological implications: from dendritic cell homing to vaccine design. Semin Immunol. 2008 Apr; 20(2):147-56.
    View in: PubMed
    Score: 0.010
  34. Part II: Fibroblasts preferentially migrate in the direction of principal strain. Biomech Model Mechanobiol. 2008 Jun; 7(3):215-25.
    View in: PubMed
    Score: 0.010
  35. Synthesis and in vitro characterization of an ABC triblock copolymer for siRNA delivery. Bioconjug Chem. 2007 May-Jun; 18(3):736-45.
    View in: PubMed
    Score: 0.009
  36. Non-viral gene delivery: multifunctional polyplexes as locally triggerable nonviral vectors. Gene Ther. 2006 Oct; 13(19):1371-2.
    View in: PubMed
    Score: 0.009
  37. Sustained release of human growth hormone from in situ forming hydrogels using self-assembly of fluoroalkyl-ended poly(ethylene glycol). Biomaterials. 2005 Sep; 26(25):5259-66.
    View in: PubMed
    Score: 0.009
  38. Poly(ethylene glycol) hydrogels formed by conjugate addition with controllable swelling, degradation, and release of pharmaceutically active proteins. J Control Release. 2005 Feb 16; 102(3):619-27.
    View in: PubMed
    Score: 0.008
  39. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol. 2005 Jan; 23(1):47-55.
    View in: PubMed
    Score: 0.008
  40. Tissue and cell engineering. Curr Opin Biotechnol. 2004 Oct; 15(5):381-2.
    View in: PubMed
    Score: 0.008
  41. Towards a fully-synthetic substitute of alginate: development of a new process using thermal gelation and chemical cross-linking. Biomaterials. 2004 Sep; 25(21):5115-24.
    View in: PubMed
    Score: 0.008
  42. Engineered fibrin matrices for functional display of cell membrane-bound growth factor-like activities: study of angiogenic signaling by ephrin-B2. Biomaterials. 2004 Jul; 25(16):3245-57.
    View in: PubMed
    Score: 0.008
  43. MMP-2 sensitive, VEGF-bearing bioactive hydrogels for promotion of vascular healing. J Biomed Mater Res A. 2004 Mar 15; 68(4):704-16.
    View in: PubMed
    Score: 0.008
  44. Heterophilic interactions between cell adhesion molecule L1 and alphavbeta3-integrin induce HUVEC process extension in vitro and angiogenesis in vivo. Angiogenesis. 2004; 7(3):213-23.
    View in: PubMed
    Score: 0.008
  45. Biopolymeric delivery matrices for angiogenic growth factors. Cardiovasc Pathol. 2003 Nov-Dec; 12(6):295-310.
    View in: PubMed
    Score: 0.008
  46. Materials as morphogenetic guides in tissue engineering. Curr Opin Biotechnol. 2003 Oct; 14(5):551-8.
    View in: PubMed
    Score: 0.007
  47. Targeted Polymersome Delivery of a Stapled Peptide for Drugging the Tumor Protein p53:BCL-2-Family Axis in Diffuse Large B-Cell Lymphoma. ACS Nano. 2023 12 12; 17(23):23374-23390.
    View in: PubMed
    Score: 0.007
  48. Membrane-localized neoantigens predict the efficacy of cancer immunotherapy. Cell Rep Med. 2023 08 15; 4(8):101145.
    View in: PubMed
    Score: 0.007
  49. Achieving tissue-level softness on stretchable electronics through a generalizable soft interlayer design. Nat Commun. 2023 07 26; 14(1):4488.
    View in: PubMed
    Score: 0.007
  50. Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics. Proc Natl Acad Sci U S A. 2003 Apr 29; 100(9):5413-8.
    View in: PubMed
    Score: 0.007
  51. Chemisorbed poly(propylene sulphide)-based copolymers resist biomolecular interactions. Nat Mater. 2003 Apr; 2(4):259-64.
    View in: PubMed
    Score: 0.007
  52. Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severity. Sci Adv. 2022 10 07; 8(40):eabn3777.
    View in: PubMed
    Score: 0.007
  53. Robust coupling of angiogenesis and osteogenesis by VEGF-decorated matrices for bone regeneration. Acta Biomater. 2022 09 01; 149:111-125.
    View in: PubMed
    Score: 0.007
  54. Biologically engineered protein-graft-poly(ethylene glycol) hydrogels: a cell adhesive and plasmin-degradable biosynthetic material for tissue repair. Biomacromolecules. 2002 Jul-Aug; 3(4):710-23.
    View in: PubMed
    Score: 0.007
  55. Kidney repair and regeneration: perspectives of the NIDDK (Re)Building a Kidney consortium. Kidney Int. 2022 05; 101(5):845-853.
    View in: PubMed
    Score: 0.007
  56. Molecular properties of fibrin-based matrices for promotion of angiogenesis in vitro. Microvasc Res. 2001 Nov; 62(3):315-26.
    View in: PubMed
    Score: 0.007
  57. Immunoengineering approaches for cytokine therapy. Am J Physiol Cell Physiol. 2021 08 01; 321(2):C369-C383.
    View in: PubMed
    Score: 0.006
  58. Covalently conjugated VEGF--fibrin matrices for endothelialization. J Control Release. 2001 May 14; 72(1-3):101-13.
    View in: PubMed
    Score: 0.006
  59. Development of growth factor fusion proteins for cell-triggered drug delivery. FASEB J. 2001 May; 15(7):1300-2.
    View in: PubMed
    Score: 0.006
  60. Fibronectin modulates macrophage adhesion and FBGC formation: the role of RGD, PHSRN, and PRRARV domains. J Biomed Mater Res. 2001 Apr; 55(1):79-88.
    View in: PubMed
    Score: 0.006
  61. Conjugate addition reactions combined with free-radical cross-linking for the design of materials for tissue engineering. Biomacromolecules. 2001; 2(2):430-41.
    View in: PubMed
    Score: 0.006
  62. Incorporation of heparin-binding peptides into fibrin gels enhances neurite extension: an example of designer matrices in tissue engineering. FASEB J. 1999 Dec; 13(15):2214-24.
    View in: PubMed
    Score: 0.006
  63. Growth factors with enhanced syndecan binding generate tonic signalling and promote tissue healing. Nat Biomed Eng. 2020 04; 4(4):463-475.
    View in: PubMed
    Score: 0.006
  64. Synthetic 3D PEG-Anisogel Tailored with Fibronectin Fragments Induce Aligned Nerve Extension. Biomacromolecules. 2019 11 11; 20(11):4075-4087.
    View in: PubMed
    Score: 0.006
  65. A bioactive injectable bulking material; a potential therapeutic approach for stress urinary incontinence. Biomaterials. 2019 06; 206:41-48.
    View in: PubMed
    Score: 0.005
  66. Quantitative intrinsic auto-cathodoluminescence can resolve spectral signatures of tissue-isolated collagen extracellular matrix. Commun Biol. 2019; 2:69.
    View in: PubMed
    Score: 0.005
  67. Murine macrophage behavior on peptide-grafted polyethyleneglycol-containing networks. Biotechnol Bioeng. 1998 Jul 05; 59(1):2-9.
    View in: PubMed
    Score: 0.005
  68. Modified Magnesium Hydroxide Nanoparticles Inhibit the Inflammatory Response to Biodegradable Poly(lactide- co-glycolide) Implants. ACS Nano. 2018 07 24; 12(7):6917-6925.
    View in: PubMed
    Score: 0.005
  69. Self-assembly and steric stabilization at heterogeneous, biological surfaces using adsorbing block copolymers. Chem Biol. 1998 Mar; 5(3):177-83.
    View in: PubMed
    Score: 0.005
  70. Incorporation of adhesion peptides into nonadhesive hydrogels useful for tissue resurfacing. J Biomed Mater Res. 1998 Feb; 39(2):266-76.
    View in: PubMed
    Score: 0.005
  71. Microfluidic production of bioactive fibrin micro-beads embedded in crosslinked collagen used as an injectable bulking agent for urinary incontinence treatment. Acta Biomater. 2018 02; 67:156-166.
    View in: PubMed
    Score: 0.005
  72. Oxidation-sensitive polymersomes as vaccine nanocarriers enhance humoral responses against Lassa virus envelope glycoprotein. Virology. 2017 12; 512:161-171.
    View in: PubMed
    Score: 0.005
  73. Bioengineering strategies for inducing tolerance in autoimmune diabetes. Adv Drug Deliv Rev. 2017 05 15; 114:256-265.
    View in: PubMed
    Score: 0.005
  74. Advances in pancreatic islet monolayer culture on glass surfaces enable super-resolution microscopy and insights into beta cell ciliogenesis and proliferation. Sci Rep. 2017 04 12; 7:45961.
    View in: PubMed
    Score: 0.005
  75. Vaccine nanocarriers: Coupling intracellular pathways and cellular biodistribution to control CD4 vs CD8 T cell responses. Biomaterials. 2017 07; 132:48-58.
    View in: PubMed
    Score: 0.005
  76. Local induction of lymphangiogenesis with engineered fibrin-binding VEGF-C promotes wound healing by increasing immune cell trafficking and matrix remodeling. Biomaterials. 2017 07; 131:160-175.
    View in: PubMed
    Score: 0.005
  77. (Re)Building a Kidney. J Am Soc Nephrol. 2017 May; 28(5):1370-1378.
    View in: PubMed
    Score: 0.005
  78. Primary Human and Rat ß-Cells Release the Intracellular Autoantigens GAD65, IA-2, and Proinsulin in Exosomes Together With Cytokine-Induced Enhancers of Immunity. Diabetes. 2017 02; 66(2):460-473.
    View in: PubMed
    Score: 0.005
  79. Aberrant Accumulation of the Diabetes Autoantigen GAD65 in Golgi Membranes in Conditions of ER Stress and Autoimmunity. Diabetes. 2016 09; 65(9):2686-99.
    View in: PubMed
    Score: 0.004
  80. IGF-1-containing multi-layered collagen-fibrin hybrid scaffolds for bladder tissue engineering. Acta Biomater. 2016 09 01; 41:75-85.
    View in: PubMed
    Score: 0.004
  81. Tubular Compressed Collagen Scaffolds for Ureteral Tissue Engineering in a Flow Bioreactor System. Tissue Eng Part A. 2015 Sep; 21(17-18):2334-45.
    View in: PubMed
    Score: 0.004
  82. Fibrin gels engineered with pro-angiogenic growth factors promote engraftment of pancreatic islets in extrahepatic sites in mice. Biotechnol Bioeng. 2015 Sep; 112(9):1916-26.
    View in: PubMed
    Score: 0.004
  83. Biomaterials in tissue engineering. Biotechnology (N Y). 1995 Jun; 13(6):565-76.
    View in: PubMed
    Score: 0.004
  84. 6-Thioguanine-loaded polymeric micelles deplete myeloid-derived suppressor cells and enhance the efficacy of T cell immunotherapy in tumor-bearing mice. Cancer Immunol Immunother. 2015 Aug; 64(8):1033-46.
    View in: PubMed
    Score: 0.004
  85. Densely crosslinked polymer networks of poly(ethylene glycol) in trimethylolpropane triacrylate for cell-adhesion-resistant surfaces. J Biomed Mater Res. 1995 Feb; 29(2):207-15.
    View in: PubMed
    Score: 0.004
  86. Molecularly engineered self-assembling membranes for cell-mediated degradation. Adv Healthc Mater. 2015 Mar 11; 4(4):602-12.
    View in: PubMed
    Score: 0.004
  87. Inhibition of thrombosis and intimal thickening by in situ photopolymerization of thin hydrogel barriers. Proc Natl Acad Sci U S A. 1994 Jun 21; 91(13):5967-71.
    View in: PubMed
    Score: 0.004
  88. Bioluminescent and micro-computed tomography imaging of bone repair induced by fibrin-binding growth factors. Acta Biomater. 2014 Oct; 10(10):4377-89.
    View in: PubMed
    Score: 0.004
  89. Clonal, self-renewing and differentiating human and porcine urothelial cells, a novel stem cell population. PLoS One. 2014; 9(2):e90006.
    View in: PubMed
    Score: 0.004
  90. Growth factors engineered for super-affinity to the extracellular matrix enhance tissue healing. Science. 2014 Feb 21; 343(6173):885-8.
    View in: PubMed
    Score: 0.004
  91. Enhancing efficacy of anticancer vaccines by targeted delivery to tumor-draining lymph nodes. Cancer Immunol Res. 2014 May; 2(5):436-47.
    View in: PubMed
    Score: 0.004
  92. Polyimide-polyethylene glycol block copolymers: synthesis, characterization, and initial evaluation as a biomaterial. J Biomater Sci Polym Ed. 1994; 6(4):313-23.
    View in: PubMed
    Score: 0.004
  93. Fibronectin binding modulates CXCL11 activity and facilitates wound healing. PLoS One. 2013; 8(10):e79610.
    View in: PubMed
    Score: 0.004
  94. In situ cell manipulation through enzymatic hydrogel photopatterning. Nat Mater. 2013 Nov; 12(11):1072-8.
    View in: PubMed
    Score: 0.004
  95. Preparation of well-defined ibuprofen prodrug micelles by RAFT polymerization. Biomacromolecules. 2013 Sep 09; 14(9):3314-20.
    View in: PubMed
    Score: 0.004
  96. The promotion of endothelial cell attachment and spreading using FNIII10 fused to VEGF-A165. Biomaterials. 2013 Aug; 34(24):5958-68.
    View in: PubMed
    Score: 0.004
  97. Proteolytic processing regulates placental growth factor activities. J Biol Chem. 2013 Jun 21; 288(25):17976-89.
    View in: PubMed
    Score: 0.004
  98. Tenascin C promiscuously binds growth factors via its fifth fibronectin type III-like domain. PLoS One. 2013; 8(4):e62076.
    View in: PubMed
    Score: 0.004
  99. Covalently immobilized laminin peptide Tyr-Ile-Gly-Ser-Arg (YIGSR) supports cell spreading and co-localization of the 67-kilodalton laminin receptor with alpha-actinin and vinculin. J Biol Chem. 1993 Apr 15; 268(11):8053-9.
    View in: PubMed
    Score: 0.004
  100. Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix. Proc Natl Acad Sci U S A. 2013 Mar 19; 110(12):4563-8.
    View in: PubMed
    Score: 0.004
  101. A feeder-free, defined three-dimensional polyethylene glycol-based extracellular matrix niche for culture of human embryonic stem cells. Biomaterials. 2013 May; 34(14):3571-80.
    View in: PubMed
    Score: 0.004
  102. Avoidance of photoactivation in the epifluorescence video microscopic observation of thrombosis. J Biomed Mater Res. 1992 Nov; 26(11):1535-42.
    View in: PubMed
    Score: 0.004
  103. Improving the osteogenic potential of BMP-2 with hyaluronic acid hydrogel modified with integrin-specific fibronectin fragment. Biomaterials. 2013 Jan; 34(3):704-12.
    View in: PubMed
    Score: 0.003
  104. Surface-grafted cell-binding peptides in tissue engineering of the vascular graft. Ann N Y Acad Sci. 1992 Oct 13; 665:253-8.
    View in: PubMed
    Score: 0.003
  105. Reduction-sensitive tioguanine prodrug micelles. Mol Pharm. 2012 Oct 01; 9(10):2812-8.
    View in: PubMed
    Score: 0.003
  106. Engineering the regenerative microenvironment with biomaterials. Adv Healthc Mater. 2013 Jan; 2(1):57-71.
    View in: PubMed
    Score: 0.003
  107. Precision intracellular delivery based on optofluidic polymersome rupture. ACS Nano. 2012 Sep 25; 6(9):7850-7.
    View in: PubMed
    Score: 0.003
  108. Engineering approaches to immunotherapy. Sci Transl Med. 2012 Aug 22; 4(148):148rv9.
    View in: PubMed
    Score: 0.003
  109. Vascular endothelial cell adhesion and spreading promoted by the peptide REDV of the IIICS region of plasma fibronectin is mediated by integrin alpha 4 beta 1. J Biol Chem. 1992 Jul 15; 267(20):14019-26.
    View in: PubMed
    Score: 0.003
  110. Size- and charge-dependent non-specific uptake of PEGylated nanoparticles by macrophages. Int J Nanomedicine. 2012; 7:799-813.
    View in: PubMed
    Score: 0.003
  111. Twenty-third annual Pezcoller Symposium: engineering influences in cancer research. Cancer Res. 2012 Feb 15; 72(4):841-4.
    View in: PubMed
    Score: 0.003
  112. Tissue engineering in the vascular graft. Cytotechnology. 1992; 10(3):189-204.
    View in: PubMed
    Score: 0.003
  113. Surface-immobilized polyethylene oxide for bacterial repellence. Biomaterials. 1992; 13(7):417-20.
    View in: PubMed
    Score: 0.003
  114. Engineered insulin-like growth factor-1 for improved smooth muscle regeneration. Biomaterials. 2012 Jan; 33(2):494-503.
    View in: PubMed
    Score: 0.003
  115. PEG-b-PPS-b-PEI micelles and PEG-b-PPS/PEG-b-PPS-b-PEI mixed micelles as non-viral vectors for plasmid DNA: tumor immunotoxicity in B16F10 melanoma. Biomaterials. 2011 Dec; 32(36):9839-47.
    View in: PubMed
    Score: 0.003
  116. Toxicity and exposure of an adenovirus containing human interferon alpha-2b following intracystic administration in cynomolgus monkeys. Gene Ther. 2012 Jul; 19(7):742-51.
    View in: PubMed
    Score: 0.003
  117. An RGD spacing of 440 nm is sufficient for integrin alpha V beta 3-mediated fibroblast spreading and 140 nm for focal contact and stress fiber formation. J Cell Biol. 1991 Sep; 114(5):1089-100.
    View in: PubMed
    Score: 0.003
  118. Biological responses to polyethylene oxide modified polyethylene terephthalate surfaces. J Biomed Mater Res. 1991 Jul; 25(7):829-43.
    View in: PubMed
    Score: 0.003
  119. Endothelial cell-selective materials for tissue engineering in the vascular graft via a new receptor. Biotechnology (N Y). 1991 Jun; 9(6):568-72.
    View in: PubMed
    Score: 0.003
  120. A collagen-poly(lactic acid-co-?-caprolactone) hybrid scaffold for bladder tissue regeneration. Biomaterials. 2011 Jun; 32(16):3969-76.
    View in: PubMed
    Score: 0.003
  121. Human endothelial cell interactions with surface-coupled adhesion peptides on a nonadhesive glass substrate and two polymeric biomaterials. J Biomed Mater Res. 1991 Feb; 25(2):223-42.
    View in: PubMed
    Score: 0.003
  122. Biocompatible dispersions of carbon nanotubes: a potential tool for intracellular transport of anticancer drugs. Nanoscale. 2011 Mar; 3(3):925-8.
    View in: PubMed
    Score: 0.003
  123. Carbon monoxide-releasing micelles for immunotherapy. J Am Chem Soc. 2010 Dec 29; 132(51):18273-80.
    View in: PubMed
    Score: 0.003
  124. PPS nanoparticles as versatile delivery system to induce systemic and broad mucosal immunity after intranasal administration. Vaccine. 2011 Jan 17; 29(4):804-12.
    View in: PubMed
    Score: 0.003
  125. High-density collagen gel tubes as a matrix for primary human bladder smooth muscle cells. Biomaterials. 2011 Feb; 32(6):1543-8.
    View in: PubMed
    Score: 0.003
  126. Local thrombin synthesis and fibrin formation in an in vitro thrombosis model result in platelet recruitment and thrombus stabilization on collagen in heparinized blood. J Lab Clin Med. 1990 Nov; 116(5):636-50.
    View in: PubMed
    Score: 0.003
  127. Human embryonic stem cell-derived microvascular grafts for cardiac tissue preservation after myocardial infarction. Biomaterials. 2011 Feb; 32(4):1102-9.
    View in: PubMed
    Score: 0.003
  128. Engineered aprotinin for improved stability of fibrin biomaterials. Biomaterials. 2011 Jan; 32(2):430-8.
    View in: PubMed
    Score: 0.003
  129. The effect of matrix characteristics on fibroblast proliferation in 3D gels. Biomaterials. 2010 Nov; 31(32):8454-64.
    View in: PubMed
    Score: 0.003
  130. Covalent surface immobilization of Arg-Gly-Asp- and Tyr-Ile-Gly-Ser-Arg-containing peptides to obtain well-defined cell-adhesive substrates. Anal Biochem. 1990 Jun; 187(2):292-301.
    View in: PubMed
    Score: 0.003
  131. Compressed collagen gel: a novel scaffold for human bladder cells. J Tissue Eng Regen Med. 2010 Feb; 4(2):123-30.
    View in: PubMed
    Score: 0.003
  132. Cell-responsive hydrogel for encapsulation of vascular cells. Biomaterials. 2009 Sep; 30(26):4318-24.
    View in: PubMed
    Score: 0.003
  133. Bone healing induced by local delivery of an engineered parathyroid hormone prodrug. Biomaterials. 2009 Mar; 30(9):1763-71.
    View in: PubMed
    Score: 0.003
  134. Controlling integrin specificity and stem cell differentiation in 2D and 3D environments through regulation of fibronectin domain stability. Biomaterials. 2009 Feb; 30(6):1089-97.
    View in: PubMed
    Score: 0.003
  135. Bioluminescence imaging of calvarial bone repair using bone marrow and adipose tissue-derived mesenchymal stem cells. Biomaterials. 2008 Feb; 29(4):427-37.
    View in: PubMed
    Score: 0.002
  136. The effect of enzymatically degradable poly(ethylene glycol) hydrogels on smooth muscle cell phenotype. Biomaterials. 2008 Jan; 29(3):314-26.
    View in: PubMed
    Score: 0.002
  137. Biomolecular hydrogels formed and degraded via site-specific enzymatic reactions. Biomacromolecules. 2007 Oct; 8(10):3000-7.
    View in: PubMed
    Score: 0.002
  138. Mechanisms of 3-D migration and matrix remodeling of fibroblasts within artificial ECMs. Acta Biomater. 2007 Sep; 3(5):615-29.
    View in: PubMed
    Score: 0.002
  139. RNA interference targeting hypoxia inducible factor 1alpha reduces post-operative adhesions in rats. J Surg Res. 2007 Aug; 141(2):162-70.
    View in: PubMed
    Score: 0.002
  140. Part I: A novel in-vitro system for simultaneous mechanical stimulation and time-lapse microscopy in 3D. Biomech Model Mechanobiol. 2008 Jun; 7(3):203-14.
    View in: PubMed
    Score: 0.002
  141. Enzymatic formation of modular cell-instructive fibrin analogs for tissue engineering. Biomaterials. 2007 Sep; 28(26):3856-66.
    View in: PubMed
    Score: 0.002
  142. Recombinant protein-co-PEG networks as cell-adhesive and proteolytically degradable hydrogel matrixes. Part II: biofunctional characteristics. Biomacromolecules. 2006 Nov; 7(11):3019-29.
    View in: PubMed
    Score: 0.002
  143. Targeting dendritic cells with biomaterials: developing the next generation of vaccines. Trends Immunol. 2006 Dec; 27(12):573-9.
    View in: PubMed
    Score: 0.002
  144. Visualization and analysis of mural thrombogenesis on collagen, polyurethane and nylon. Biomaterials. 1986 Sep; 7(5):354-63.
    View in: PubMed
    Score: 0.002
  145. Activation of cell-survival transcription factor NFkappaB in L1Ig6-stimulated endothelial cells. J Biomed Mater Res A. 2006 Jun 01; 77(3):542-50.
    View in: PubMed
    Score: 0.002
  146. Peptide-matrix-mediated gene transfer of an oxygen-insensitive hypoxia-inducible factor-1alpha variant for local induction of angiogenesis. Proc Natl Acad Sci U S A. 2006 Feb 21; 103(8):2506-11.
    View in: PubMed
    Score: 0.002
  147. Molecularly engineered PEG hydrogels: a novel model system for proteolytically mediated cell migration. Biophys J. 2005 Aug; 89(2):1374-88.
    View in: PubMed
    Score: 0.002
  148. Enhanced endothelial cell retention on shear-stressed synthetic vascular grafts precoated with RGD-cross-linked fibrin. Tissue Eng. 2005 May-Jun; 11(5-6):887-95.
    View in: PubMed
    Score: 0.002
  149. 3D morphology of cell cultures: a quantitative approach using micrometer synchrotron light tomography. Microsc Res Tech. 2005 Apr 15; 66(6):289-98.
    View in: PubMed
    Score: 0.002
  150. Mechanical properties, proteolytic degradability and biological modifications affect angiogenic process extension into native and modified fibrin matrices in vitro. Biomaterials. 2005 Apr; 26(12):1369-79.
    View in: PubMed
    Score: 0.002
  151. Neurite extension and in vitro myelination within three-dimensional modified fibrin matrices. J Neurobiol. 2005 Apr; 63(1):1-14.
    View in: PubMed
    Score: 0.002
  152. Effects of protein and gene transfer of the angiopoietin-1 fibrinogen-like receptor-binding domain on endothelial and vessel organization. J Biol Chem. 2005 Jun 10; 280(23):22445-53.
    View in: PubMed
    Score: 0.002
  153. Poly (4-vinylimidazole) as nonviral gene carrier: in vitro and in vivo transfection. Acta Biomater. 2005 Mar; 1(2):165-72.
    View in: PubMed
    Score: 0.002
  154. Non-viral gene delivery for local and controlled DNA release. J Control Release. 2005 Jan 20; 102(1):263-75.
    View in: PubMed
    Score: 0.002
  155. Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity. J Control Release. 2005 Jan 03; 101(1-3):93-109.
    View in: PubMed
    Score: 0.002
  156. The selective modulation of endothelial cell mobility on RGD peptide containing surfaces by YIGSR peptides. Biomaterials. 2005 Jan; 26(2):167-74.
    View in: PubMed
    Score: 0.002
  157. Synthetic extracellular matrices for in situ tissue engineering. Biotechnol Bioeng. 2004 Apr 05; 86(1):27-36.
    View in: PubMed
    Score: 0.002
  158. Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth. Circ Res. 2004 Apr 30; 94(8):1124-32.
    View in: PubMed
    Score: 0.002
  159. RGD-containing peptide GCRGYGRGDSPG reduces enhancement of osteoblast differentiation by poly(L-lysine)-graft-poly(ethylene glycol)-coated titanium surfaces. J Biomed Mater Res A. 2004 Mar 01; 68(3):458-72.
    View in: PubMed
    Score: 0.002
  160. Peptide functionalized poly(L-lysine)-g-poly(ethylene glycol) on titanium: resistance to protein adsorption in full heparinized human blood plasma. Biomaterials. 2003 Dec; 24(27):4949-58.
    View in: PubMed
    Score: 0.002
  161. Evaluation of pH-dependent membrane-disruptive properties of poly(acrylic acid) derived polymers. Eur J Pharm Biopharm. 2003 Sep; 56(2):237-46.
    View in: PubMed
    Score: 0.002
  162. RGD-grafted poly-L-lysine-graft-(polyethylene glycol) copolymers block non-specific protein adsorption while promoting cell adhesion. Biotechnol Bioeng. 2003 Jun 30; 82(7):784-90.
    View in: PubMed
    Score: 0.002
  163. Photopolymerized hyaluronic acid-based hydrogels and interpenetrating networks. Biomaterials. 2003 Mar; 24(6):893-900.
    View in: PubMed
    Score: 0.002
  164. Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur J Cardiothorac Surg. 2000 May; 17(5):587-91.
    View in: PubMed
    Score: 0.001
  165. Effects of fibrin micromorphology on neurite growth from dorsal root ganglia cultured in three-dimensional fibrin gels. J Biomed Mater Res. 1998 Jun 15; 40(4):551-9.
    View in: PubMed
    Score: 0.001
  166. Surface characteristics and biocompatibility of lactide-based poly(ethylene glycol) scaffolds for tissue engineering. J Biomater Sci Polym Ed. 1998; 9(7):667-80.
    View in: PubMed
    Score: 0.001
  167. Alkylation of cellulosic membranes results in reduced complement activation. J Biomater Sci Polym Ed. 1996; 7(8):707-14.
    View in: PubMed
    Score: 0.001
  168. A new photopolymerizable blood vessel glue that seals human vessel anastomoses without augmenting thrombogenicity. Plast Reconstr Surg. 1995 Apr; 95(5):901-7.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.